- Filed
- Feb 10, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2022 · Feb 9, 2022 | 70.83M sh |
| Capex | Q3 2022 · Dec 31, 2021 | $573.78K |
| Capex | Q3 2022 · Dec 31, 2020 | $20.79K |
| Operating Cash Flow | Q3 2022 · Dec 31, 2021 | −$5.72M |
| Operating Cash Flow | Q3 2022 · Dec 31, 2020 | −$1.62M |
| Cash And Equivalents | Q3 2022 · Dec 31, 2021 | $46.64M |
| Cash And Equivalents | Q3 2022 · Mar 31, 2021 | $10.39M |
| Cash And Equivalents restated | Q3 2022 · Dec 31, 2020 | $5.7M |
| Cash And Equivalents | Q3 2022 · Mar 31, 2020 | $146.43K |
| Stockholders Equity | Q3 2022 · Dec 31, 2021 | $67.83M |
| Stockholders Equity | Q3 2022 · Mar 31, 2021 | $15.13M |
| Current Liabilities | Q3 2022 · Dec 31, 2021 | $619.6K |
| Current Liabilities | Q3 2022 · Mar 31, 2021 | $1.07M |
| Total Liabilities | Q3 2022 · Dec 31, 2021 | $619.6K |
| Total Liabilities | Q3 2022 · Mar 31, 2021 | $1.55M |
| Current Assets | Q3 2022 · Dec 31, 2021 | $46.81M |
| Current Assets | Q3 2022 · Mar 31, 2021 | $10.47M |
| Total Assets | Q3 2022 · Dec 31, 2021 | $68.45M |
| Total Assets | Q3 2022 · Mar 31, 2021 | $16.68M |
| Sga Expense | Q3 2022 · Dec 31, 2021 | $3.39M |
| Sga Expense | Q3 2022 · Dec 31, 2021 | $16.43M |
| Sga Expense restated | Q3 2022 · Dec 31, 2020 | $158.36K |
| Sga Expense | Q3 2022 · Dec 31, 2020 | $524.27K |
| Net Income | Q3 2022 · Dec 31, 2021 | −$5.44M |
| Net Income | Q3 2022 · Dec 31, 2021 | −$22.65M |
| Net Income | Q3 2022 · Dec 31, 2020 | −$1.3M |
| Net Income | Q3 2022 · Dec 31, 2020 | −$2.42M |
| Operating Income | Q3 2022 · Dec 31, 2021 | −$5.45M |
| Operating Income | Q3 2022 · Dec 31, 2021 | −$22.55M |
| Operating Income | Q3 2022 · Dec 31, 2020 | −$252.44K |
| Operating Income | Q3 2022 · Dec 31, 2020 | −$1.1M |